and chilled in a 1:3 NaCl : ice bath (-10 °C). With stirring, N-methylmorpholine (NMM, 1.10 mL, 10 mmol, 2 equiv) and isobutylchloroformate (IBCF, 0.65 mL, 5 mmol, 1 equiv) were slowly added. The reaction was stirred at -10°C for 15 min, and N-Boc-1,2-phenylenediamine (S1, 1.0413g, 5 mmol, 1 equiv) was added. The reaction was allowed to proceed at -10°C for 2 h, and then at room temperature overnight (≥ 14 h). Upon completion, the solvent was removed by rotary evaporation. The residue was brought up in 40 mL of ethyl acetate, and extracted against 40 mL each of 1 M Na 2 HPO 4 , brine, 5% NaHCO 3 , and brine. The aqueous layers were combined and extracted against 100 mL of ethyl acetate. The organic layers were combined, dried by rotary 
Synthesis of α-N-Fmoc-L-thioalanine-(N-Boc)-2-aminoanilide (S3).
In an argon atmosphere, S2 (1.6593 g, 3.3 mmol, 1 equiv) and Lawesson's reagent (1.0036 g, 2.5 mmol, 0.75 equiv) were refluxed in 30 mL of CH 2 Cl 2 for 18 h. Upon completion, the solvent was removed by rotary evaporation. The crude product was purified by flash chromatography in ethyl acetate/petroleum ether (35:65 v/v) to yield a pale yellow foam (1.5214 g, 2.9 mmol, 89% yield). 
Synthesis of α-N-Fmoc-L-thioalanine-benzotriazolide (S4) In argon atmosphere, S3
(1.0861 g, 2.1 mmol, 1 equiv) was dissolved in 10 mL of CH 2 Cl 2 and chilled to 0 ˚C on ice. 10 mL of an ice cold TFA/CH 2 Cl 2 (50:50 v/v) solution was slowly added, and the reaction was allowed to proceed at 0 ˚C for 2 h. Upon completion, the solvent was removed by rotary evaporation. The residue was dissolved in glacial AcOH (9.5 mL) and water (0.5 mL), and then chilled to 0 ˚C on ice. With stirring, NaNO 2 (0.2202 g, 3.2 mmol, 1.5 equiv) was added in small portions over 5 min. The reaction was allowed to proceed at 0 ˚C for 30 min, and then quenched with 30 mL of ice cold water. Table S1 through (Table S1 ). Isolated product was characterized by MALDI MS (   Table S3) , quantified by UV-Vis absorption, split into 20 nmol aliquots, and then lyophilized until further use. X = 7-methoxycoumarinylalanine; G o = glycolic acid. mM Na 2 HPO 4 , pH 7.0). 10 µL of t-BuSH was added, followed by 10 µL of freshly prepared 10x VA-044 stock (100 mM in argon-purged water). The reaction was allowed to proceed at 37 °C for 2 h under argon atmosphere, and then quickly quenched by chilling to 0 °C on ice. Excess t-BuSH was removed by a stream of argon, and then the crude mixture was diluted into H 2 O for analysis by reverse phase HPLC on a Luna C8 analytical column using gradient 2. Fractions were collected, and then analyzed by MALDI-TOF MS and UV-Vis absorption spectroscopy. Yield was quantified by integrating peak areas in HPLC chromatogram. See Fig. S4 for proposed mechanisms of radical initiated desulfurization and deselenization.
One-Pot Ligation Deselenization with Selenocystine

Raney Nickel Desulfurization for Thioamide Compatibility Studies
Peptide 1 (10 nmol, ε 325 = 12,000 M -1 cm -1 ) was dissolved in desulfurization buffer (100 µL, 100 mM Na 2 HPO 4 , 10 mM TCEP, pH 5.8), and then Raney nickel (0.1 mg) was added. The reaction was allowed to proceed at room temperature for 12 h, and then supernatant was recovered by centrifugation at 13.2 krpm for 20 min. The crude was analyzed by analytical RP-HPLC on a Luna C8 analytical column using gradient 2. Individual fractions were collected manually, and then analyzed by MALDI-TOF and UV-Vis absorption spectroscopy. by reverse phase HPLC on a Luna C8 analytical column using gradient 3. Fractions were collected, and then analyzed by MALDI-TOF MS and UV-Vis absorption spectroscopy. Yield was quantified by integrating peak areas in the HPLC chromatograms. All subsequent condition optimization experiments were conducted using permutations of this standard procedure.
VA-044 Desulfurization for Condition Optimization
TCEP Dosage Dependence
The reactions were conducted similarly to the standard procedure, except that 1.25x buffer stocks of various TCEP concentration were used, and that a 2 h reaction time was adopted. At low TCEP concentrations, side product S9 was observed, with a disulfide bond between Cys and ambient t-BuSH (Fig. S5 ). The side product was not observed at high TCEP concentrations.
VA-044 Dosage Dependence
Reactions were conducted similarly to the standard procedure, except that 10x VA-044 stocks at various concentrations were used for 2 h or 18 h (Fig. S6 ). Above 0.1 mM, no distinction was observed at the range of VA-044 concentrations tested. At very low VA-044 concentration, however, the reaction was significantly slower and messier − at 2 h, while all other conditions showed complete reaction, minimal product formation was observed at 0.01 mM VA-044. At 18 h, the reaction was still not complete, with additional side peaks in the chromagram.
Oxygen Tolerance Reactions were conducted similarly to the standard procedure, except that an undegassed buffer stock was used with 5 min or 10 min reaction time. While both reactions completed within 10 min, the undegassed condition resulted in a slightly slower kinetics -80% complete (as measured by reactant consumed) by 5 min as compared to 89% complete for the degassed condition (Fig. S7 ).
Denaturant Tolerance Reactions were conducted similarly to the standard procedure, except that a 1.25x buffer stock with denaturant was used with 2 h reaction time. No difference was found as compared to denaturant free conditions (Fig. S8 ).
Prolonged Reaction with Cys/Thioamide-Containing Peptide Reactions were conducted similarly to the standard procedure, except that longer reaction times were adopted. Side products, particularly 6, accumulated over time (Fig. S9 ).
Thioacetamide Suppression of Thioamide Degradation
Reactions were conducted similarly to the standard procedure using Ala/thioamide peptide 5'. Thioamide-to-oxoamide conversion was effectively suppressed after 18 h of exposure (Fig. S10) .
Thioacetamide Dosage Dependence Reactions were conducted similarly to the standard procedure, except that buffers with various concentrations of thioacetamide were used with 18 h reaction time. Suppression of thioamide-to-oxoamide conversion was effective over the wide range of concentrations tested; at very high concentration, thioacetamide may quench ambient radicals, leading to slower kinetics (Fig. S11 ).
Oxygen and Denaturant Tolerance in the Presence of Thioacetamide Reactions were
conducted similarly to the control reactions without thioacetamide for 18 h. No distinction was found with the addition of thioacetamide (Fig. S12) .
Characterization of Cys-to-Ser Conversion Side Products
We were surprised to find a residual peak at 21.8 min even in the presence of thioacetamide, which should suppress thioamideto-oxoamide conversion and abolish side product 6. Upon a closer examination of the MALDI-TOF MS and UV-Vis absorption spectra (Fig. S14) , we realized that the residual peak represents a separate side product S10 where a Cys-to-Ser conversion took place with thioamide intact. The conversion could result from quenching of alkyl radical by water or dissolved oxygen in the reaction solution (Fig. S13) ; in fact, a similar conversion had been reported for oxygen-related complications in Sec deselenization. 3, 4 We believe both water and oxygen contribute to the Cys side reaction observed here -a 2% conversion still took place in argon purged buffer, as compared to 3% in non-degassed buffer.
To prove the identity of the residual peak, we synthesized three control peptides − Ala/oxoamide peptide 6', Ser/thioamide peptide S10', and Cys/ oxoamide peptide S11' (prime symbol denotes the genuine peptide standards to distinguish them from species identified in desulfurization reactions). We showed that 6' and S10' both eluted at 21.8 min under the gradient used, but had vastly different UV-Vis absorption profiles. While S11' shares the same expected mass with S10', it eluted at a different retention time, and of course, did not exhibit thioamide absorption at 272 nm (Fig. S14) . Therefore, we conclude that the 2% residual peak corresponded to Cys-to-Ser conversion side product S10, and that thioamide-to-oxoamide conversion was fully suppressed by thioacetamide. S16 ), from which the target sample concentration was extrapolated. The residual PhSH/PhS-after acidification-lyophilization of a saturated PhSH solution initially at pH 7.0 was determined to be (3.4 ± 1.9) µM. Althought this value is somewhat different from the theoretical value of 73 nM at pH 1.6, it represents a significant reduction from the 7.3 mM PhSH concentration at pH 7.0 and is negligible with respect to concentrations of all other reagents in the desulfurization reaction. One-Pot Ligation-Desulfurization A phosphate buffer stock (40 mM TCEP, 100 mM Na 2 HPO 4 , pH 7.0) was freshly prepared and degassed by argon purging. 2% PhSH (v/v) was added, and then pH was quickly adjusted back to 7.0 under argon atmosphere. Thioester 7a and peptide 7b (50 nmol each) were each dissolved in 25 µL of the above buffer, and then combined.
Synthesis of
The reaction was allowed to proceed at 37 °C overnight.
For desulfurization, 10 µL of the ligation crude was removed, acidified with 100 µL of 1% trifluoroacetic acid in water, and then quickly frozen and lyophilized. The crude residue was brought up in 80 µL of freshly degassed 1.25x desulfurization buffer (50 mM TCEP, 125 mM Na 2 HPO 4 , pH 7.0), and then t-BuSH and VA-044 were added to proceed with the standard desulfurization procedure. Upon completion, all crude reaction samples were diluted into H 2 O, and analyzed by reverse phase HPLC on a Luna C8 analytical column using gradient 3. Individual fractions were collected, and then analyzed by MALDI-TOF MS and UV-Vis absorption spectroscopy. Individual fractions were characterized by MALDI-TOF MS, and dried by lyophilization.
Synthesis and Purification of GB1
Synthesis and Purification of Cys-GB1 25-56 -OH (9) Crude peptide was purchased from
Genscript and received as a lyophilized white powder. Crude product was dissolved in 50:50 Analytical HPLC runs were performed on a Luna C8 column using gradient 14.
Desulfurization to obtain GB1 1-56 Leu S
-OH (10b)
To the crude ligation reaction, 400 µL degased desulfurization buffer (200 mM Na 2 HPO 4 , 6 M GnHCl, 500 mM TCEP, 250 mM Thioacetamide, pH 7.0) were added and spin-concentrated to about 80 µL using a Millipore Amincon Ultracel 3K Spin Filter Unit at 13.2k rpm for 60 min at 4°C. This procedure was repeated one more time. To 80 µL of buffer exchanged ligation product 10a, 10 µL t-BuSH and 10 µL of a 0.5 M VA-044 solution in desulfurization buffer were added. The reaction was allowed to proceed at 37°C and was monitored by MALDI-TOF MS (Fig. S17) , since the desulfurized product 10b
has the same retention time as 10a. After 23 h the reaction was complete and the crude reaction mixture was diluted to 3 mL with 0.1% TFA in H 2 O and purified by reverse phase HPLC using gradient 15. Analytical HPLC runs were performed on a Luna C8 column using gradient 14. The product yield (71%) was determined from UV/Vis spectra of isolated products using 274 
One-Pot Ligation Desulfurization
Attempts to obtain GB1 1-56 Leu 
Desulfurization of Pen/Thioamide-Containing Peptide
Reaction was conducted using standard desulfurization procedure with thioacetamide. Briefly, Peptide 11 (10 nmol, ε 325 = 12,000 M -1 cm -1 ) was dissolved in 80 µL of argon-purged 1.25x buffer stock (50 mM TCEP, 125 mM thioacetamide, 125 mM Na 2 HPO 4 , pH 7.0). t-BuSH and VA-044 stock were then added, and the reaction was allowed to proceed at 37 °C for 10-60 min. The crude was analyzed by reverse phase HPLC on a Luna C8 analytical column using gradient 11, and characterized by MALDI-TOF MS.
After 60 minutes the reaction was complete as shown in 
Synthesis of Boc-Sec(S-i-Pr)-OH
Synthesis of Sec-Containing Peptide
Peptide 12 was synthesized using SPPS procedure on Rink amide resin. Sec was introduced as Boc-Sec(S-i-Pr)-OH (S14) using standard HBTU activation method. The peptide was cleaved with 12:1:1:26 trifluoroacetic acid/2-propanethiol/triisopropylsilane/CH 2 Cl 2 , and then purified by reverse phase HPLC. 12 was isolated as the primary product, with an intramolecular hemiselenide bond between Sec and Cys.
Deselenization of Sec/Cys/Thioamide-Containing Peptide Deselenization buffer (40 mM TCEP, 40 mM DTT, 200 mM phosphate, pH 7.0) was freshly prepared and degassed by the freezepump-thaw method. Peptide 12 (10 nmol, ε 325 = 12,000 M -1 cm -1 ) was dissolved in 100 µL of the above buffer, and then the reaction was allowed to proceed at 37 ˚C for 18 h. Upon completion, the reaction was chilled to 0 ˚C on ice, and then 100 µL of argon-purged CH 3 CN was added. The supernatant was recovered by centrifugation at 13.2 krpm for 20 min, diluted into argon-purged H 2 O (650 µL), and then analyzed by reserve phase HPLC on a Luna C8 analytical column using gradient 3. Fractions were collected and analyzed for MALDI-TOF MS and UV-Vis absorption.
4-Mercaptophenylacetic Acid (MPAA) as Deselenization Additive
Reaction was conducted similarly to the standard procedure, except that a buffer stock containing 10 mM MPAA was used. MPAA was chosen over PhSH for its low volatility. 
Synthesis of Boc-Sec(S-t-Bu)-OH
Synthesis of Boc-Sec(S-t-Bu)-OCH 2 CN (S16)
Tetrahydrofuran (THF) and diisopropylethylamine (DIPEA) were freshly degassed by the freeze-pump-thaw method. S15 (0.2194 g, 0.64 mmol, 1 equiv) was dissolved in degassed THF (7.7 mL), and chilled to 0 ˚C on ice. DIPEA (335 µL, 1.9 mmol, 3 equiv) was added, followed by ClCH 2 CN (2.0 mL, 32 mmol, 50 equiv). The reaction was allowed to proceed on ice for 2 h, and then at room temperature overnight (≥ 12 h) under an argon atmosphere. Upon completion, the reaction mixture was concentrated by rotary evaporation, and then purified by flash chromatography in 5:5 ethyl acetate/petroleum ether. freshly degassed by the freeze-pump-thaw method. S17 (0.0200 g, 22 µmol, 1 equiv) was dissolved in degassed THF (1 mL) and chilled to 0 °C on ice. Triisopropylsilane (23 µL, 110 µmol, 5 equiv) was added, followed by t-BuSH (205 µL, 2.2 mmol, 100 equiv). Trifluoroacetic acid (1 mL) was added dropwise, and then the reaction was allowed to proceed at room temperature for 2 h under an argon atmosphere. Upon completion, the reaction was dried by rotary evaporation. The residue was brought up in degassed CH 2 Cl 2 (1 mL), and then extracted with degassed H 2 O (1 mL × 3) to recover the product. The crude was directly purified by reverse phase HPLC using a binary solvent system of water/acetonitrile with 0.1% trifluoroacetic acid (Table S4 through Table S6) .
Synthesis of Other H-Sec(SR)-Ade Donors (16a-e) All other adenosine donors were derivatized from 16c through thiol exchange: H 2 O was freshly degassed by the freeze-pump-thaw method. 16c (0.0056 g, 11 µmol, 1 equiv) was dissolved in 1 mL of degassed H 2 O. 100 µL of an appropriate thiol (ethanethiol for 16a; 2-propanethiol for 16b; thiophenol for 16d; benzyl mercaptan for 16e) was added, and the reaction was allowed to proceed at room temperature for 2 h under an argon atmosphere. Upon completion, excess thiol was evaporated by a stream of argon.
The aqueous crude was directly purified by reverse phase HPLC (Table S4 through Table S6 mercaptoethanol (BME) was used in our purification, to avoid complications with the hemiselenide side chains. For protein expression, E. coli BL21-Gold (DE3) cells were transformed with the plasmid, and selected on an LB plate in the presence of ampicillin (Amp, 100 µg/mL) by overnight growth at 37 °C. 5 mL LB media was inoculated with a single colony, and then grown at 37 °C in the presence of Amp (100 µg/mL) until OD 600 ≥ 0.5. The primary culture was diluted into 1 L of LB media with Amp (100 mg/L), and grown at 37 °C until OD 600 = 0.6. 100 mg of and Sec adenosine donor stock (6.25 µL) were thoroughly mixed, and then AaT (7.81 µL, 0.8 mg/mL) was added to initiate the reaction. The reaction was allowed to proceed at 37 ˚C for 4 h under an argon atmosphere. Upon completion, the reaction was quenched with 1% acetic acid in degassed H 2 O (187.5 µL). Degassed acetone (1 mL) was added, and then the mixture was kept at -20 °C for 1 h to precipitate the enzyme. Supernatant was recovered after centrifugation at 13,200 rpm and 4 ˚C for 20 min, and then excess acetone was removed by rotary evaporation. The residue was diluted into degassed H 2 O (800 µL), and then analyzed by reverse phase HPLC on a Jupiter C18 analytical column using gradient 17.
For quantification, peak identities were assigned based on MALDI-TOF MS (Table S7) , and then transfer efficiencies were calculated from peak areas monitored at 325 nm. For each adenosine donor, the transfer efficiency was reported as the average value with standard deviation from three independent trials. Oxygen Tolerance Reactions were conducted similarly as the standard procedure, except that non-degassed water and buffers were used ( Figure S25 ). Transfer efficiencies were reported as the average value from three independent trials.
Expression and Purification of αS 6-140 (S18) Expression and purification were performed as previously described.
